Frequency of Contraception Documentation in Women With Systemic Lupus Erythematosus and Rheumatoid Arthritis Within the Rheumatology Informatics System for Effectiveness Registry
| العنوان: | Frequency of Contraception Documentation in Women With Systemic Lupus Erythematosus and Rheumatoid Arthritis Within the Rheumatology Informatics System for Effectiveness Registry |
|---|---|
| المؤلفون: | Amanda M Eudy, Megan E.B. Clowse, Jing Li, Mehret Birru Talabi, Gabriela Schmajuk |
| المصدر: | Arthritis Care & Research. 75:590-596 |
| بيانات النشر: | Wiley, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | medicine.medical_specialty, Multivariate analysis, business.industry, Women of color, medicine.disease, Rheumatology, Documentation, Rheumatoid arthritis, Informatics, Internal medicine, Family medicine, medicine, Diagnosis code, Medical prescription, business |
| الوصف: | We sought to understand the frequency of contraception documentation for women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in a large US electronic health record (EHR)-based registry and to identify disparities by teratogen prescription and patient race and ethnicity.Contraception documentation from structured data fields within the Rheumatology Informatics System for Effectiveness (RISE) registry was collected for women of childbearing age (18-45 years) in 2018 who had at least 2 visits with International Classification of Diseases, Ninth Revision or Tenth Revision, diagnosis codes for SLE or RA (at any time). Univariate and multivariate analyses compared the frequency of contraception documentation based on patient characteristics including diagnosis, age, race, and teratogenicity of prescribed antirheumatic medications.In 2018, there were 9,826 women of childbearing age with SLE and 19,009 with RA, of whom 9.1% had any contraception documented. Rates of contraceptive documentation were significantly lower for women with SLE (adjusted odds ratio [OR] 0.84 [95% confidence interval (95% CI) 0.76-0.92]). Women of Hispanic ethnicity and Black and Asian race were all less likely than White women to have contraception documentation. Teratogen prescription was associated with higher rates of contraception documentation for women with RA but not SLE (RA adjusted OR 1.31 [95% CI 1.16-1.47]; SLE adjusted OR 1.08 [95% CI 0.91-1.28]).There are large gaps in contraception documentation within the RISE registry that are particularly stark among women of color. Although these data likely underestimate contraception use, they highlight that most rheumatologists do not have a systematic approach to collecting and recording this information in the EHR. |
| تدمد: | 2151-4658 2151-464X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd8a8e4819d20816591910b5c3ff3137 https://doi.org/10.1002/acr.24803 |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.doi.dedup.....bd8a8e4819d20816591910b5c3ff3137 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 21514658 2151464X |
|---|